Literature DB >> 10463199

Targeting TGF-beta overexpression: maximizing the antifibrotic actions of angiotensin II blockade in anti-Thy1 glomerulonephritis.

H Peters1, W A Border, N A Noble.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10463199     DOI： 10.1093/ndt/14.suppl_4.22

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  3 in total

Review 1.  Extracellular matrix molecules: potential targets in pharmacotherapy.

Authors:  Hannu Järveläinen; Annele Sainio; Markku Koulu; Thomas N Wight; Risto Penttinen
Journal:  Pharmacol Rev       Date:  2009-06       Impact factor: 25.468

2.  Effects of TJN-598, a new selective phosphodiesterase type IV inhibitor on anti-Thy1 nephritis in rats.

Authors:  Chiharu Sadakane; Yoshio Kase; Junichi Koseki; Yoshihiro Hasegawa; Shoichiro Shindo; Hirobumi Maruyama; Shuichi Takeda; Hiroshi Takeda; Tomohisa Hattori
Journal:  Clin Exp Nephrol       Date:  2010-09-04       Impact factor: 2.801

3.  ACE Inhibition in Anti-Thy1 Glomerulonephritis Limits Proteinuria but Does Not Improve Renal Function and Structural Remodeling.

Authors:  Peter E Westerweel; Jaap A Joles; Krista den Ouden; Roel Goldschmeding; Maarten B Rookmaaker; Marianne C Verhaar
Journal:  Nephron Extra       Date:  2012-01-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.